Research Progress in Flavonoids as Potential Anticancer Drug Including Synergy with Other Approaches

Yusuf Hussain1, Suaib Luqman1, Abha Meena1

  • 1Molecular Bioprospection Department of Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow-226015, Uttar Pradesh, India.

Abstract

Insights

Flavonoids show promise in combination cancer therapy by targeting cancer cells and overcoming drug resistance. However, their bioavailability challenges can be addressed with advanced delivery systems for improved efficacy.

Area of Science:

  • Phytochemistry and Pharmacology
  • Oncology Research
  • Drug Delivery Systems

Background:

  • Conventional chemotherapy faces challenges in advanced cancer due to multidrug resistance and off-target effects on healthy cells.
  • Flavonoids offer a synergistic approach, targeting supplementary cancer cell death pathways and overcoming resistance mechanisms.
  • This review explores the potential and limitations of flavonoids in cancer treatment.

Purpose of the Study:

  • To discuss the potential of flavonoids as anticancer agents in combination therapies.
  • To review the pharmacokinetic limitations of flavonoids and strategies to overcome them.
  • To highlight successful synergistic studies and novel drug delivery systems for flavonoids in oncology.

Main Methods:

  • A comprehensive literature search was conducted using databases such as PubMed, Scopus, and Google Scholar.
  • Keywords included "Anticancer drugs", "flavonoids", "oncology research", and "pharmacokinetics" to identify relevant studies.

Main Results:

  • Flavonoids, as dietary phytochemicals, inhibit cell signaling pathways involved in multidrug resistance and cancer progression, sparing normal cells.
  • Their potential for synergistic therapy is established, but low absorption and high metabolism limit bioavailability.
  • Novel approaches like derivatization and nano-complexes show promise in enhancing flavonoid pharmacokinetics and pharmacodynamics.

Conclusions:

  • Flavonoids represent a promising phytochemical class for combination anticancer therapy with conventional drugs or nanoparticles.
  • Addressing pharmacokinetic and pharmacodynamic challenges through innovative delivery systems is crucial for their clinical application.
  • Methodologies for establishing flavonoids as safe and effective anticancer agents are discussed, paving the way for their use in cancer treatment.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K